USPTO serial 79330694
MNEMO THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 5, 2023
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MNEMO THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jill Anderfuren
Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP550 West Adams StreetSuite 300Chicago, IL 60062Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions | ACTIVE | — |
| 005 | Pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for the treatment of cancer and tumors using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; antigens, antibodies, cells for therapeutic use | ACTIVE | — |
| 010 | apparatus and instruments for carrying out tests and diagnostics for medical use, namely, medical imaging, biopsies, genetic and molecular analysis ; medical apparatus and instruments for identifying, screening, and analyzing antigens for medical use; medical apparatus for reading of analytical tests, namely molecular, blood and genetic testing | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; Custom manufacturing of antigens, antibodies, T-cells; Providing manufacturing information in the field of pharmaceuticals | ACTIVE | — |
| 042 | Scientific research services for medical purposes, namely, medical research; Scientific research and development services for identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific information with regard to immunotherapy; Scientific research and development services, namely, providing services for the identification, analysis, authentication, purification and development of biological material from a genomic platform; Scientific research, namely, epigenetic antigen identification and screening services for therapeutic research purposes; Scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; Scientific and medical research services, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses | ACTIVE | — |
| 044 | Providing medical information with regard to immunotherapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MNEMO THERAPEUTICS
- Other trademarks owned by MNEMO THERAPEUTICS
- Other trademarks owned by MNEMO THERAPEUTICS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MNEMO THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 26, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 5, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 20, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 20, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 31, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 31, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 2, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 19, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2023 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Mar 5, 2023 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Mar 5, 2023 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Mar 5, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 1, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 1, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 1, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 31, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 30, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 30, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 30, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 12, 2022 | CRSN | CORRECTION SENT TO IB | — |
| Dec 12, 2022 | CRSN | CORRECTION SENT TO IB | — |
| Dec 7, 2022 | CRCR | CORRECTION CREATED FOR IB | — |
| Dec 7, 2022 | CRCR | CORRECTION CREATED FOR IB | — |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 6, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |